03:34 PM EDT, 07/04/2025 (MT Newswires) -- Spectral Medical ( EDTXF ) (EDT.TO, a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, was slightly higher late Friday afternoon as it filed a preliminary short-form base shelf prospectus of up to $100 million, but also said stakeholders "should not assume that this filing is a sign that we would be imminently raising capital."

The prospectus was filed with provincial securities regulatory authorities, except Quebec.

According to a company statement, the base shelf prospectus, when made final, will allow Spectral to qualify the distribution by way of a prospectus of "up to $100 million of common shares, debt securities, subscription receipts, warrants and units, or any combination thereof, from time to time, during the 25-month period that the final short form base shelf prospectus is effective."

Specific terms of any offering will be established in a prospectus supplement.

"Given the upcoming milestones and catalysts which may be impactful to the company, combined with our ongoing commitment to have maximum flexibility and optimize our balance sheet, we have filed a base shelf prospectus," said CEO Chris Seto. "Our stakeholders should not assume that this filing is a sign that we would be imminently raising capital."

The company is trading up $0.01 to $0.82 a share.

Price: 0.82, Change: +0.01, Percent Change: +1.23